# Tenon Medical, Inc (TNON) · Edgar & Edgarette company card

> Tenon Medical (TNON) grew revenue 20.4% in FY2025 to $4 million, operating margin -324% against a 1.2% median for surgical & medical instruments & apparatus, equity 46.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1560293 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/TNON) · [JSON](https://www.pops4.com/boards/company/TNON.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $4M |
| Revenue growth, 1 year | 20.4% |
| Revenue growth per year | 122.8% |
| Operating margin | -324.3% (prior year -420.1%) |
| Net margin | -318.4% |
| Operating cash flow | −$11M |
| Capital spending | $273,000 |
| Free cash flow | −$11M |
| Cash | $4M |
| Long-term debt | — |
| Total assets | $11M |
| Total equity | $5M |
| Equity ÷ assets | 46.8% |
| Return on equity | -249.1% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -29.53 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Beneish M: -1.78 (above the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative; operating loss: a margin of -324.3% in FY2025; revenue is hard to predict: its 80% range is ±47%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $3.9M (FY2025). Experience: revenue up 20.4% on the year, up 122.8% a year over 4 years; operating margin -324.3%, up from -420.1%. Soundness: equity 46.8% of assets, return on equity -249.1%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $3.5M and $9.6M next year (method v4.1: its own 2-year record of growth weighed at 25% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $3.2M to $10.3M. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -324.3% against a 1.2% median; growth 20.4% against 11.6%.

Range logged 2026-09-24, receipt 562142f4f3b7ea7d, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 2, latest 2026-05-22 ([filing](https://www.sec.gov/Archives/edgar/data/1560293/000121390026060662/0001213900-26-060662-index.htm))
- Item 5.02 Director or officer change: 1, latest 2026-06-12 ([filing](https://www.sec.gov/Archives/edgar/data/1560293/000121390026068390/0001213900-26-068390-index.htm))

## Recent filings

- 8-K · filed 2026-10-22 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1560293/000121390026111740/0001213900-26-111740-index.htm)
- 8-K · filed 2026-09-16 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1560293/000121390026100596/0001213900-26-100596-index.htm)
- 8-K · filed 2026-09-09 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1560293/000121390026098232/0001213900-26-098232-index.htm)
- 8-K · filed 2026-08-31 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1560293/000121390026095686/0001213900-26-095686-index.htm)
- 8-K · filed 2026-08-24 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1560293/000121390026092944/0001213900-26-092944-index.htm)
- 10-Q · filed 2026-08-13 · [filing](https://www.sec.gov/Archives/edgar/data/1560293/000121390026089258/0001213900-26-089258-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001560293.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1560293

## Cite

POPS4, Edgar & Edgarette: Tenon Medical, Inc (TNON) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/TNON. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.